Gelonghui, Feb. 6, 丨 Chenyi Pharmaceutical (603811.SH) announced that on February 6, 2024, the company learned that based on confidence in the company's future development and recognition of long-term investment value, in order to promote the company's sustainable, stable and healthy development, Ms. Yan Xiaoling, the controlling shareholder of the company, increased her holdings of the company's shares by a total of 213,022 million shares, accounting for 0.065% of the company's total shares.
诚意药业(603811.SH)：控股股东一致行动人颜晓玲增持合计21.30万股
Sincerity Pharmaceutical (603811.SH): Controlling shareholder Yan Xiaoling increased her holdings by a total of 21.3 million shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.